Peptide therapy claims on TikTok: separating hype from evidence

What did @gersande_lph actually say?

Honestly? It's nearly impossible to tell. The transcript is a garbled, incoherent stream of phrases about parties, outfits, wigs, cars, and someone named Rachmarsi. There are no identifiable claims about peptides, healing, recovery, or any health topic. This video appears to have been miscategorized or the auto-transcription failed completely.

The hashtags point to French university culture, specifically the "monmaster" application process for French master's degree programs, "droit" (law), and "fac" (university). The creator is almost certainly a French law student talking about academic stress, not a peptide therapist. The caption "ET VOUS ??" translates to "AND YOU ??" in English, which fits a relatable student experience video far better than any health content.

The 264K views likely reflect viral student content, not health advice traction. Attributing peptide category claims to this video is a categorization error, plain and simple.

Does the science back this up?

There is no science to evaluate here because no health claims were made. However, since this video was flagged under peptide therapy, it's worth briefly establishing what the actual evidence base looks like for the peptides commonly discussed in this category, so readers have context if they arrived here looking for that.

BPC-157 has shown tissue repair effects in rodent models (Sikiric et al., 2018, Current Pharmaceutical Design), but has zero completed human clinical trials as of this writing. TB-500, a synthetic fragment of thymosin beta-4, similarly shows wound healing signals in animal studies but lacks human RCT data. GHK-Cu copper peptide has some human cosmetic trial data (Pickart and Margolina, 2018, Biomolecules) but nothing that supports systemic therapeutic claims. MK-677 is an oral ghrelin mimetic with some IGF-1 elevation data in older adults (Chapman et al., 1996, NEJM) but long-term safety data is genuinely thin.

None of these have FDA approval for the indications they're typically marketed toward online.

What did they get wrong (or right)?

This is not a fair question to apply to this video. @gersande_lph did not get anything right or wrong about peptides because they did not talk about peptides. Applying a peptide fact-check framework to a French student's university application video is the error here, not anything the creator said.

What we can say is that the auto-transcription of this video is so poor it appears to have translated French speech into phonetically similar but meaningless English phrases. "Rachmarsi" is almost certainly a French word or name rendered unrecognizable. "Enerse" and "Ine Leiksmarsi" follow the same pattern. This is a known failure mode for English-language speech-to-text models processing French audio.

Readers should know: viral French student content gets swept into English-language health content databases through keyword mismatches and transcription errors more often than platform operators tend to acknowledge.

What should you actually know?

If you landed here looking for a fact-check on peptide therapy claims, the short version is this: the evidence base for most research peptides is stuck at the animal-study or early-phase-human stage. That does not mean they are useless, but it does mean the confident optimization claims you see on social media are running well ahead of the data.

Telehealth platforms that prescribe compounded peptides operate under FDA oversight of compounding pharmacies (503A and 503B), and the legal and safety landscape shifted in 2024 when the FDA moved BPC-157 and TB-500 onto the "Category 2" list of bulk substances, meaning compounding pharmacies can no longer legally compound them for patient use in the US without navigating significant regulatory hurdles.

If a provider is offering these to you, ask specifically which compounding pharmacy they use, whether it is 503B accredited, and what current FDA guidance applies. That is not a conversation to skip.